Afyren SAS
AFYREN SAS provides biobased products to replace petroleum-based molecules in France. The company offers acetic, propionic, butyric and isobutyric, valeric and isovaleric, and caproic acids. Its products are used in the flavors and fragrances, lubricants and functional fluids, feed, food, life sciences, and materials science markets. The company was founded in 2012 and is headquartered in Clermon… Read more
Afyren SAS (ALAFY) - Net Assets
Latest net assets as of June 2025: €46.16 Million EUR
Based on the latest financial reports, Afyren SAS (ALAFY) has net assets worth €46.16 Million EUR as of June 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€51.46 Million) and total liabilities (€5.30 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | €46.16 Million |
| % of Total Assets | 89.7% |
| Annual Growth Rate | 39.38% |
| 5-Year Change | 169.24% |
| 10-Year Change | N/A |
| Growth Volatility | 137.99 |
Afyren SAS - Net Assets Trend (2018–2024)
This chart illustrates how Afyren SAS's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Afyren SAS (2018–2024)
The table below shows the annual net assets of Afyren SAS from 2018 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | €52.70 Million | -14.73% |
| 2023-12-31 | €61.80 Million | -12.93% |
| 2022-12-31 | €70.98 Million | -8.84% |
| 2021-12-31 | €77.86 Million | +297.77% |
| 2020-12-31 | €19.57 Million | +255.16% |
| 2019-12-31 | €5.51 Million | -23.28% |
| 2018-12-31 | €7.18 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Afyren SAS's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 2329000000.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | €522.00K | 0.99% |
| Other Comprehensive Income | €-9.43 Million | -17.90% |
| Other Components | €85.41 Million | 162.07% |
| Total Equity | €52.70 Million | 100.00% |
Afyren SAS Competitors by Market Cap
The table below lists competitors of Afyren SAS ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
INTACT FINANCIAL
BE:I5U
|
$1.77 Million |
|
Max Resource Corp
PINK:MXROF
|
$1.77 Million |
|
PANELESMATIC SOLUTIONS PUBLIC COMPANY LIMITED
BK:PANEL
|
$1.77 Million |
|
Capelli SA
PA:ALCAP
|
$1.77 Million |
|
Courtois S.A
PA:COUR
|
$1.77 Million |
|
Borqs Technologies Inc.
NASDAQ:BRQSF
|
$1.77 Million |
|
North Arrow Minerals Inc
PINK:NHAWF
|
$1.77 Million |
|
ELECTRONIC ARTS (ERT.SG)
STU:ERT
|
$1.77 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Afyren SAS's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 61,799,000 to 52,698,000, a change of -9,101,000 (-14.7%).
- Net loss of 9,754,000 reduced equity.
- Share repurchases of 20,000 reduced equity.
- New share issuances of 144,000 increased equity.
- Other comprehensive income decreased equity by 4,755,000.
- Other factors increased equity by 5,284,000.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | €-9.75 Million | -18.51% |
| Share Repurchases | €20.00K | -0.04% |
| Share Issuances | €144.00K | +0.27% |
| Other Comprehensive Income | €-4.75 Million | -9.02% |
| Other Changes | €5.28 Million | +10.03% |
| Total Change | €- | -14.73% |
Book Value vs Market Value Analysis
This analysis compares Afyren SAS's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 1.48x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
- The price-to-book ratio has decreased from 10.76x to 1.48x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2018-12-31 | €0.28 | €3.00 | x |
| 2019-12-31 | €0.21 | €3.00 | x |
| 2020-12-31 | €0.76 | €3.00 | x |
| 2021-12-31 | €3.02 | €3.00 | x |
| 2022-12-31 | €2.75 | €3.00 | x |
| 2023-12-31 | €2.38 | €3.00 | x |
| 2024-12-31 | €2.02 | €3.00 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Afyren SAS utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -18.51%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -340.81%
- • Asset Turnover: 0.05x
- • Equity Multiplier: 1.11x
- Recent ROE (-18.51%) is below the historical average (-15.81%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2019 | -32.37% | -76.96% | 0.15x | 2.90x | €-2.34 Million |
| 2020 | -10.90% | -53.45% | 0.11x | 1.83x | €-4.09 Million |
| 2021 | -4.64% | -118.87% | 0.03x | 1.20x | €-11.39 Million |
| 2022 | -12.96% | -266.20% | 0.04x | 1.20x | €-16.30 Million |
| 2023 | -15.51% | -283.69% | 0.05x | 1.14x | €-15.77 Million |
| 2024 | -18.51% | -340.81% | 0.05x | 1.11x | €-15.02 Million |
Industry Comparison
This section compares Afyren SAS's net assets metrics with peer companies in the Specialty Chemicals industry.
Industry Context
- Industry: Specialty Chemicals
- Average net assets among peers: $2,330,871,810
- Average return on equity (ROE) among peers: -20.46%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Afyren SAS (ALAFY) | €46.16 Million | -32.37% | 0.11x | $1.77 Million |
| Air Liquide SA (AI) | $19.00 Billion | 12.81% | 1.21x | $99.38 Billion |
| Arkema SA (AKE) | $1.81 Billion | -9.49% | 1.18x | $3.23 Billion |
| Carbios (ALCRB) | $13.06 Million | -16.92% | 0.05x | $126.57 Million |
| Encres Dubuit SA (ALDUB) | $19.30 Million | -6.18% | 0.26x | $2.55 Million |
| Glob Bioenergi (ALGBE) | $7.65 Million | -156.71% | 1.82x | $288.57K |
| Berkem Group SA (ALKEM) | $-163.00K | 0.00% | 0.00x | $10.44 Million |
| Plásticos Compuestos, S.A. (ALKOM) | $14.81 Million | -2.48% | 1.80x | $1.32 Million |
| Vinpai SAS (ALVIN) | $2.54 Million | 0.16% | 2.31x | $2.09 Million |
| EPC Groupe (EXPL) | $103.05 Million | -5.37% | 2.38x | $139.39 Million |